Dr. Reddy ' s Laboratories Continues its Voluntary Nationwide Recall of Levetiracetam in 0.54% Sodium Chloride Injection 1500mg/100mL Due to Mislabeling

Dr. Reddy ’ s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY) announced that it ’ s wholly owned subsidiary, Dr Reddy ’ s Laboratories, Inc is continuing its voluntary nationwide recall of lot ABD807 of Levetiracetram in 0.54% Sodium Chloride Injection, 1,500 mg/100 mL (15 mg/mL) single-dose infusion bags to the hospital level in U.S.A.
Source: Food and Drug Administration - Category: Food Science Source Type: news